Article Excerpt: FDA advisory committees will hold a joint session Tuesday to evaluate the safety and efficacy of extended-release oxycodone capsules (Remoxy ER), with the drug formulated as a thick gel that the developer says will resist certain common forms of abuse.
Full Article: https://tinyurl.com/yd7rsfwp
Article Source: MedPage Today